4th Operationalize Expanded Access Programs Summit The Westin Boston Seaport District, Boston
Following the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnesses a critical rise.
Back in Boston as the only industry forum defining global regulations for EAP and your definitive networking opportunity to connect with managed access teams from other leading and new companies that are immersing themselves in this evolving field of opportunity and life-changing support.
Reunite with 120+ industry experts setting up and leading EAPs at the 4th Operationalize Expanded Access Programs Summit and gain practical take aways on how to construct a reliable system, define a clear exit strategy, understand updated local and global regulations, and determine the role of real-world data to optimize the operationalization of your EAP.
Don’t miss out on your opportunity to be amongst physicians, patients and passionate EAP and clinical supply experts from Novartis, Daiichi Sankyo, GSK, AstraZeneca, Gilead, Biogen, Sanofi, Eli Lilly, Regeneron, and many more to discover novel strategies in overcoming operational hurdles and deliver life-saving treatments to patients more efficiently.
![](https://weeklyaffair.us/wp-content/themes/dryfta/images/url.png )
Drug Developer - Pre-Conference Workshop Day Only: USD 1298.00, Drug Developer - Conference Only: USD 2999.00, Drug Developer - Conference + Pre-Conference Workshop Day: USD 4197.00, Academic - Pre-Conference Workshop Day Only: USD 1098.00, Academic - Conference Only: USD 2599.00, Academic - Conference + Pre-Conference Workshop Day: USD 3597.00, Vendor - Conference Only: USD 3699.00, Vendor - Conference + Pre-Conference Workshop Day: USD 5097.00
Advertisements